Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis

References

• Chen JC, Lin TM, Chen YL, et al. RHD 1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol 2004;122:193–8
   PubMed Web of Science ®Google Scholar
• Avent ND. RHD genotyping from maternal plasma: guidelines and technical challenges. Methods Mol Biol 2008;444:185–201
   PubMedGoogle Scholar
• Daniels G. The molecular genetics of blood group polymorphism. Transpl Immunol 2005;14:143–53
   PubMed Web of Science ®Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7
   PubMed Web of Science ®Google Scholar
• Farina A, Leshane ES, Romero R, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005;193:421–5
   PubMed Web of Science ®Google Scholar
• Galbiati S, Smid M, Gambini D, et al. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005;117:243–8
   PubMed Web of Science ®Google Scholar
• Li Y, Holzgreve W, Din E, et al. Cell-free DNA in maternal plasma: is it all a question of size? Ann N Y Acad Sci 2006;1075:81–7
   PubMed Web of Science ®Google Scholar
• Liu FM, Wang XY, Feng X, et al. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis. Acta Obstet Gynecol Scand 2007;86:535–41
   PubMed Web of Science ®Google Scholar
• Puszyk WM, Crea F, Old RW. Noninvasive prenatal diagnosis of aneuploidy using cell-free nucleic acids in maternal blood: promises and unanswered questions. Prenat Diagn 2008;28:1–6
   PubMed Web of Science ®Google Scholar
• Guo QW, Zhou YL. Noninvasive prenatal diagnosis of single gene disorders through cell-free fetal DNA in maternal blood. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009;26:410–13
   PubMedGoogle Scholar
• Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood – a meta-analysis. Am J Obstet Gynecol 2006;195:1163–73
   PubMed Web of Science ®Google Scholar
• Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK. Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 2003;85:300–6
   PubMed Web of Science ®Google Scholar
• Scheffer PG, Van Der Schoot CE, Page-Christiaens GC, De Haas M. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 2011;118:1340–8
   PubMed Web of Science ®Google Scholar
• Clausen FB, Jakobsen TR, Rieneck K, et al. Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD. PLoS One 2013;8:e76990
   PubMed Web of Science ®Google Scholar
• Macher HC, Noguerol P, Medrano-Campillo P, et al. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Clin Chim Acta 2011;413:490–4
   PubMed Web of Science ®Google Scholar
• Bombard AT, Akolekar R, Farkas DH, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn 2011;31:802–8
   PubMed Web of Science ®Google Scholar
• Tynan JA, Angkachatchai V, Ehrich M, et al. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol 2011;204:251 e1–6
   PubMed Web of Science ®Google Scholar
• Atamaniuk J, Stuhlmeier KM, Karimi A, Mueller MM. Comparison of PCR methods for detecting fetal RhDin maternal plasma. J Clin Lab Anal 2009;23:24–8
   PubMed Web of Science ®Google Scholar
• Clausen FB, Krog GR, Rieneck K, et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 2005;25:1040–4
   PubMed Web of Science ®Google Scholar
• Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768–75
   PubMed Web of Science ®Google Scholar
• Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95:3662–8
   PubMed Web of Science ®Google Scholar
• Gautier E, Benachi A, Giovangrandi Y, et al. RhD genotyping by maternal serum analysis: a two-year experience. Am J Obstet Gynecol 2005;192:666–9
   PubMed Web of Science ®Google Scholar
• Legler TJ, Lynen R, Maas JH, et al. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apher Sci 2002;27:217–23
   PubMed Web of Science ®Google Scholar
• Costa JM, Giovangrandi Y, Ernault P, et al. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255–60
   PubMed Web of Science ®Google Scholar
• Chim SS, Tong YK, Chiu RW, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 2005;102:14753–8
   PubMed Web of Science ®Google Scholar
• Chiu RW, Chim SS, Wong IH, et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007;170:941–50
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lo YM. Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011;16:88–93
   PubMed Web of Science ®Google Scholar
• Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211–18
   PubMed Web of Science ®Google Scholar